financetom
Business
financetom
/
Business
/
-- Fortis Brief: BMO Raised TP on higher target P/E of 18.5x as Bank believes investors will be positively bias to FTS's Near 99% regulated assets with visible growth in face of U.S. trade war uncerta
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
-- Fortis Brief: BMO Raised TP on higher target P/E of 18.5x as Bank believes investors will be positively bias to FTS's Near 99% regulated assets with visible growth in face of U.S. trade war uncerta
Feb 18, 2025 7:36 AM

10:27 AM EST, 02/18/2025 (MT Newswires) --

Price: 61.77, Change: -1.26, Percent Change: -1.99

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US to block Tempur Sealy's $4 bln buy of retailer Mattress Firm
US to block Tempur Sealy's $4 bln buy of retailer Mattress Firm
Jul 2, 2024
July 2 (Reuters) - The U.S. Federal Trade Commission is preparing to sue to block the $4 billion merger between mattress manufacturer Tempur Sealy International Inc ( TPX ) and retailer Mattress Firm, a source familiar with the matter said on Tuesday. Tempur Sealy ( TPX ) had announced the cash-and-stock deal in May 2023, seeking to add Mattress Firm's...
Eos Energy Enterprises Expands Viejas Enterprise Microgrid Project Size
Eos Energy Enterprises Expands Viejas Enterprise Microgrid Project Size
Jul 2, 2024
10:24 AM EDT, 07/02/2024 (MT Newswires) -- Eos Energy Enterprises ( EOSE ) said Tuesday its existing agreement with Indian Energy was expanded to add 25 megawatt hours of storage to the Viejas Enterprise Microgrid project, bringing the total project size to 60 MWh. The expansion is the company's largest order funded by the California Energy Commission and is expected...
Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle
Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle
Jul 2, 2024
10:21 AM EDT, 07/02/2024 (MT Newswires) -- Heron Therapeutics ( HRTX ) said Tuesday the US Food and Drug Administration acknowledged the receipt of its prior approval supplement application for Zynrelef extended-release solution vial access needle. The firm said the FDA has assigned a prescription drug user fee act goal date of Sept. 23, by which the regulator must respond....
RBC Capital Markets Outlines Highlights from Tamarack's Investor Day
RBC Capital Markets Outlines Highlights from Tamarack's Investor Day
Jul 2, 2024
10:23 AM EDT, 07/02/2024 (MT Newswires) -- Tamarack Valley Energy ( TNEYF ) 's Investor Day focused primarily on Clearwater and Charlie Lake technical presentations, plus a review of its existing five-year plan, RBC Capital Markets noted in a Tuesday note. RBC said Tamarack's guidance remained unchanged and still includes 3-5% annual growth. With material M&A behind it, field execution...
Copyright 2023-2026 - www.financetom.com All Rights Reserved